Moderna believed from pandemic beginning that BioNTech violated patent -CEO
- Country:
- Japan
Moderna Inc believed from the beginning of the COVID-19 pandemic that BioNTech SE used its intellectual property in producing a rival vaccine, Chief Executive Stephane Bancel said on Wednesday.
Moderna filed suit against BioNTech and its partner Pfizer Inc last month for patent infringement in the development of the first COVID-19 vaccine approved in the United States.
Bancel, speaking in Tokyo, said Moderna is considering building facilities in Japan to produce mRNA-derived products.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- United States
- BioNTech
- Moderna
- Japan
- Stephane Bancel
- Tokyo
- Moderna Inc
- Pfizer Inc
Advertisement
ALSO READ
Japan to expand Russia-bound export ban to li-ion batteries, industrial items
US, Philippines, Japan to tackle South China Sea incidents in trilateral summit, says Manila official
US, Philippines, Japan to tackle South China Sea incidents in trilateral summit, says Manila official
US, Philippines, Japan to tackle South China Sea row in summit
Cooperation with South Korea, Philippines important for regional security, says Japan's Kishida